Transthyretin (TTR)-Mediated Amyloidosis
2 clinical trials · Condition
◉ Watch Transthyretin (TTR)-Mediated Amyloidosis
| Record | Firm | Date |
|---|---|---|
| The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant (NCT02595983) | Alnylam Pharmaceuticals | 2015-10-01 |
| A Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy Volunteers (NCT02053454) | Alnylam Pharmaceuticals | 2014-01-01 |
Track Transthyretin (TTR)-Mediated Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.